Revaccination is also recommended 5 years after the previous dose. (Evidence level: C )
Commentary on Guideline VI.7.1
More than 75% of the dialysis patients have an adequate response to the vaccine [219] [220] [221] [222] but their antibody titres are considerably less than those of healthy vaccinated adults [219, 220, 223] and decline rapidly [219] [220] [221] .
The Advisory Committee on Immunization Practice (ACIP) recommended a standard vaccination to all dialysis patients 2 years of age or older and revaccination 3-5 years after the first dose of pneumococcal vaccine [224] . Commentary on Guideline VI.7.2
In HD patients there is an increased risk of influenzarelated mortality [225, 226] . Influenza vaccination of HD patients according to current recommendations results in an effective humoral immune response [227, 228] but the post-vaccination titre is often less in dialysis patients than in immunocompetent subjects [227] [228] [229] .
Guideline VI.7.3
A. Patient on dialysis should receive the diphtheria and tetanus toxoids as recommended for healthy people. (Evidence level: B )
Commentary on Guideline VI.7.3
All inactivated vaccines and toxoids are safe and effective when used in dialysis patients. These patients should receive the same doses and schedules recommended for immunocompetent persons [230, 231] . In adults the standard anti-tetanus vaccination produces satisfactory response but a rapid decline in antibody titres sometimes occurs leading to an absence of protection 6 months later [232] . 
